Home > Newsletters > International Pharmaceutical Regulatory Monitor > Indian Supreme Court to Hear Final Arguments in Novartis Patent Case
International Pharmaceutical Regulatory Monitor
September 2012 | Vol. 40 No. 9
Indian Supreme Court to Hear Final Arguments in Novartis Patent Case
India’s Supreme Court is set to hear final arguments Sept. 11 in a case between Novartis and the Indian patent office that could have repercussions for the country’s controversial intellectual property (IP) laws and vast generic drug industry.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.